153 related articles for article (PubMed ID: 14990989)
1. Niban gene is commonly expressed in the renal tumors: a new candidate marker for renal carcinogenesis.
Adachi H; Majima S; Kon S; Kobayashi T; Kajino K; Mitani H; Hirayama Y; Shiina H; Igawa M; Hino O
Oncogene; 2004 Apr; 23(19):3495-500. PubMed ID: 14990989
[TBL] [Abstract][Full Text] [Related]
2. Activated mammalian target of rapamycin pathway in the pathogenesis of tuberous sclerosis complex renal tumors.
Kenerson HL; Aicher LD; True LD; Yeung RS
Cancer Res; 2002 Oct; 62(20):5645-50. PubMed ID: 12384518
[TBL] [Abstract][Full Text] [Related]
3. The transcriptional profile of the kidney in Tsc2 heterozygous mutant Long Evans (Eker) rats compared to wild-type.
Sen B; Wolf DC; Hester SD
Mutat Res; 2004 May; 549(1-2):213-24. PubMed ID: 15120972
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of a rapamycin analog (CCI-779) and IFN-gamma in tuberous sclerosis mouse models.
Lee L; Sudentas P; Donohue B; Asrican K; Worku A; Walker V; Sun Y; Schmidt K; Albert MS; El-Hashemite N; Lader AS; Onda H; Zhang H; Kwiatkowski DJ; Dabora SL
Genes Chromosomes Cancer; 2005 Mar; 42(3):213-27. PubMed ID: 15578690
[TBL] [Abstract][Full Text] [Related]
5. Presence of a modifier gene(s) affecting early renal carcinogenesis in the Tsc2 mutant (Eker) rat model.
Kikuchi Y; Sudo A; Mitani H; Hino O
Int J Oncol; 2004 Jan; 24(1):75-80. PubMed ID: 14654943
[TBL] [Abstract][Full Text] [Related]
6. Presence of potent transcriptional activation domains in the predisposing tuberous sclerosis (Tsc2) gene product of the Eker rat model.
Tsuchiya H; Orimoto K; Kobayashi K; Hino O
Cancer Res; 1996 Feb; 56(3):429-33. PubMed ID: 8564946
[TBL] [Abstract][Full Text] [Related]
7. Effects of rapamycin in the Eker rat model of tuberous sclerosis complex.
Kenerson H; Dundon TA; Yeung RS
Pediatr Res; 2005 Jan; 57(1):67-75. PubMed ID: 15557109
[TBL] [Abstract][Full Text] [Related]
8. Overexpression of members of the AP-1 transcriptional factor family from an early stage of renal carcinogenesis and inhibition of cell growth by AP-1 gene antisense oligonucleotides in the Tsc2 gene mutant (Eker) rat model.
Urakami S; Tsuchiya H; Orimoto K; Kobayashi T; Igawa M; Hino O
Biochem Biophys Res Commun; 1997 Dec; 241(1):24-30. PubMed ID: 9405228
[TBL] [Abstract][Full Text] [Related]
9. Renal carcinogenesis, hepatic hemangiomatosis, and embryonic lethality caused by a germ-line Tsc2 mutation in mice.
Kobayashi T; Minowa O; Kuno J; Mitani H; Hino O; Noda T
Cancer Res; 1999 Mar; 59(6):1206-11. PubMed ID: 10096549
[TBL] [Abstract][Full Text] [Related]
10. N-terminal hamartin-binding and C-terminal GAP domain of tuberin can separate in vivo.
Momose S; Kobayashi T; Tada N; Itoyama S; Hino O
Biochem Biophys Res Commun; 2007 May; 356(3):693-8. PubMed ID: 17379185
[TBL] [Abstract][Full Text] [Related]
11. Mapping and determination of the cDNA sequence of the Erc gene preferentially expressed in renal cell carcinoma in the Tsc2 gene mutant (Eker) rat model.
Yamashita Y; Yokoyama M; Kobayashi E; Takai S; Hino O
Biochem Biophys Res Commun; 2000 Aug; 275(1):134-40. PubMed ID: 10944454
[TBL] [Abstract][Full Text] [Related]
12. The G1556S-type tuberin variant suppresses tumor formation in tuberous sclerosis 2 mutant (Eker) rats despite its deficiency in mTOR inhibition.
Shiono M; Kobayashi T; Takahashi R; Sun G; Abe M; Zhang D; Wang L; Piao X; Takagi Y; Mineki R; Taka H; Tada N; Sonobe S; Momose S; Ueda M; Hino O
Oncogene; 2008 Nov; 27(52):6690-7. PubMed ID: 18695678
[TBL] [Abstract][Full Text] [Related]
13. The mTOR/S6K signalling pathway: the role of the TSC1/2 tumour suppressor complex and the proto-oncogene Rheb.
Nobukini T; Thomas G
Novartis Found Symp; 2004; 262():148-54; discussion 154-9, 265-8. PubMed ID: 15562827
[TBL] [Abstract][Full Text] [Related]
14. Early detection of Knudson's two-hits in preneoplastic renal cells of the Eker rat model by the laser microdissection procedure.
Kubo Y; Klimek F; Kikuchi Y; Bannasch P; Hino O
Cancer Res; 1995 Mar; 55(5):989-90. PubMed ID: 7867009
[TBL] [Abstract][Full Text] [Related]
15. Selective inhibition of growth of tuberous sclerosis complex 2 null cells by atorvastatin is associated with impaired Rheb and Rho GTPase function and reduced mTOR/S6 kinase activity.
Finlay GA; Malhowski AJ; Liu Y; Fanburg BL; Kwiatkowski DJ; Toksoz D
Cancer Res; 2007 Oct; 67(20):9878-86. PubMed ID: 17942919
[TBL] [Abstract][Full Text] [Related]
16. A novel gene "Niban" upregulated in renal carcinogenesis: cloning by the cDNA-amplified fragment length polymorphism approach.
Majima S; Kajino K; Fukuda T; Otsuka F; Hino O
Jpn J Cancer Res; 2000 Sep; 91(9):869-74. PubMed ID: 11011112
[TBL] [Abstract][Full Text] [Related]
17. Identification of cDNAs induced by the tumor suppressor Tsc2 gene using a conditional expression system in Tsc2 mutant (Eker) rat renal carcinoma cells.
Orimoto K; Tsuchiya H; Sakurai J; Nishizawa M; Hino O
Biochem Biophys Res Commun; 1998 Jun; 247(3):728-33. PubMed ID: 9647762
[TBL] [Abstract][Full Text] [Related]
18. Platelet-derived growth factor-induced p42/44 mitogen-activated protein kinase activation and cellular growth is mediated by reactive oxygen species in the absence of TSC2/tuberin.
Finlay GA; Thannickal VJ; Fanburg BL; Kwiatkowski DJ
Cancer Res; 2005 Dec; 65(23):10881-90. PubMed ID: 16322235
[TBL] [Abstract][Full Text] [Related]
19. Changes in gene expression during chemical-induced nephrocarcinogenicity in the Eker rat.
Patel SK; Ma N; Monks TJ; Lau SS
Mol Carcinog; 2003 Nov; 38(3):141-54. PubMed ID: 14587099
[TBL] [Abstract][Full Text] [Related]
20. Mutation in TSC2 and activation of mammalian target of rapamycin signalling pathway in renal angiomyolipoma.
El-Hashemite N; Zhang H; Henske EP; Kwiatkowski DJ
Lancet; 2003 Apr; 361(9366):1348-9. PubMed ID: 12711473
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
